Lawsuits filed against businesses selling compounded injectables for diabetes and weight-loss Novo Nordisk and Eli Lilly, who developed and won FDA approval for their blockbuster weight-loss and diabetes medicines, Ozempic, Wegovy, Mounjaro and Zepbound, have been suing businesses who they say are marketing compounded versions of these drugs with false claims.  These medical spas, wellness clinics and compounding pharmacies are…